Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...

By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Investment markets and key developments US and ...

India and the US are key trade partners, but a formal trade deal is still missing. As talks progress, the big question is: ...

Sales of several state firms which were on line to be privatized could not be completed due to time it took to follow proper ...

Sudip Bandyopadhyay of Inditrade Capital discusses the positive outlook for the Indian pharma sector following the easing of tariff concerns. He highlights Sun Pharma's promising developments and ...

What bothers Japanese firms is Donald Trump's unpredictability and the complexity of the tariffs, according to JETRO.

Indonesia is the second ASEAN nation to strike a tariff deal after US President Donald Trump's ultimatum to a list of ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...

The 30% tariff on European goods threatened by US President Donald Trump would, if implemented, be a game-changer for Europe, wiping out whole chunks of transatlantic commerce ...